	Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions. Curr Cancer Drug Targets Ma Y, Wang M, Zhang K, Ren F, Wang Y, Zhang W, Kan C, Han F, Sun H, Sun X. PMID: 43023373 [PubMed - as supplied by publisher]
	Immune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies. Front Immunol Gu G, Du Y, Zhang H, Zheng Y, Yao Y, Yan Q. PMID: 43022561 [PubMed - indexed for MEDLINE]
	Comparison of Survival Between Patients with Hepatocellular Carcinoma Beyond the "Up-to-7" Criterion Who Received Adjuvant PD-1 Inhibitors or Active Surveillance: A Target Trial Emulation Study. J Clin Transl Hepatol Su JY, Liu Z, Yang TX, Guo PP, Luo M, Liu SP, Dong XF, Xu XL, Chen SC, Ou JJ, Chen K, Li ZC, Su Z, Yang FQ, He WH, Peng N, Wu PS, Long BB, Su H, Huang ML, Li WT, Chen WT, Li JR, Yang DL, Huang ZH, Lin LP, Huo RR, Ma YL, Ma L, Zhong XB, Zhong JH, GUIDANCE investigators. PMID: 43022106 [PubMed]
	Clinical Impact in Pancreatic Cancer Trials: Time to Raise the Bar. Ann Surg van Eijck CHJ, Katz MHG, Besselink MG. PMID: 43021448 [PubMed - as supplied by publisher]
	Histopathological findings associated with prognosis in resected ductal adenocarcinoma of the pancreas. Arq Bras Cir Dig Soares EV, Toaza E, Cambruzzi E. PMID: 43017946 [PubMed - indexed for MEDLINE]
	The Hidden Burden: Addressing Disparities in Childhood Cancer Incidence Trends. Cancer Rep (Hoboken) Metwalli H, Dadam MN, Tram LN, Nguyen TV, Huy TQ, Long TCD, Huy NT. PMID: 43017902 [PubMed - indexed for MEDLINE]
	Recent Advancements in Diagnosis and Targeted Therapy of Pancreatic Cancer. Anticancer Agents Med Chem Patil J, Kanugo A. PMID: 43017793 [PubMed - indexed for MEDLINE]
	Anlotinib Plus S-1 in Advanced Pancreatic Cancer: Efficacy, Safety, and Relevance to Chronic Cancer Care. J Coll Physicians Surg Pak Wang X, Zhang T. PMID: 43016077 [PubMed - indexed for MEDLINE]
	Prognostic factors for resectable pancreatic adenocarcinoma: a systematic review and meta-analysis. BMC Surg Shu-Jie R, Chang L, Yi J, Ran H, Yu-Hang H, Le-Lang X, Qing-Quan T, Ang L. PMID: 43015764 [PubMed - indexed for MEDLINE]
	Exploratory mendelian randomization of circulating metabolites and multi-omics characterization of ERCC1 in pancreatic cancer. Funct Integr Genomics Xiao T, Gao W, Zhu H, Zang L, Xiang W, Yan A. PMID: 43015512 [PubMed - indexed for MEDLINE]
	Noncanonical metabolic and immune checkpoint topography in cancer. Trends Cell Biol Ying H, He T, Ran L, Duan Y, Xu D. PMID: 43015179 [PubMed - as supplied by publisher]
	A New Optimal Cut-Points Selection Method for Diseases With Multiple Ordinal Stages and Its Confidence Interval Estimation. Pharm Stat An N, Tian L. PMID: 43014349 [PubMed - indexed for MEDLINE]
	Postoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Mirza W, Rafi M, Siddiqui Z, Mehboob M, Khan MZ, Khan K, Ishaq MH, Shalikh M, Altabawi M, Imtiaz A, Ali RN. PMID: 43013192 [PubMed - indexed for MEDLINE]
	Geriatric nutritional risk index as a potential prognostic indicator in pancreatic cancer: evidence from a systematic review and meta-analysis. Aging Clin Exp Res Weso, Boles, Kenig J, Mi, Grosso G, Godos J, Furnari F, W, Skwara A, Micek A. PMID: 43013127 [PubMed - indexed for MEDLINE]
	Management of an incidentally discovered pancreatic neoplasm mimicking an ovarian neoplasm during pregnancy: A case report. Medicine (Baltimore) Baek MJ, Kwak MJ, Kang H, Kim JY, Jang JH, Na ED. PMID: 43012757 [PubMed - indexed for MEDLINE]
	Randomized multicentre Phase 2 clinical trial of non-viral gene therapy for pancreatic cancer: clinical and molecular findings. Cancer Drug Resist Buscail L, Lebrin M, Hanoun N, Gourgou S, Dorat N, Vernejoul F, Cambois G, Gross F, Guimbaud R, Bournet B, Mitry E, Artru P, Ouvrier D, Flori N, Thuillier F, Barthet M, Tiraby M, Cordelier P, Thergap-2 Investigator Group. PMID: 43011677 [PubMed]
	Sex and Etiology Differences in Overall Survival and Adverse Liver Events in Hepatocellular Carcinoma: An International Multicenter Study. MedComm (2020) Xia F, Huang H, Guo B, Xu M, Gasque RA, Chen Q, Zhang Q, Wu Z, Chen W, Huang Z, Liu Y, Liu L, Han S, He S, Li D, Xiang B, Zhou C, Zhou W, Li Y, Lu S, Jiang C, Duan X, Liao Y, Gu J, Zhou B, Cai W, Zhang J, Yin H, Xia G, Wan Y, Li J, Xia X, Sun H, Wang S, Chen Y, Yuan F, Lin F, Cai W, Gao H, Ren L, Chen X, Geng T, Giannone F, Moctezuma-Velazquez C, Zhang E, Andraus W, Cheng Q, Zhang Z. PMID: 43011222 [PubMed]
	Awareness of the signs and symptoms of pancreatic cancer: a cross-sectional study from a developing country setting. Future Sci OA Rataan AO, Amawi H, Alsous M, Alrosan AZ, Albawaana A, Alzoubi KH. PMID: 43010177 [PubMed]
	Stimuli-responsive CRISPR-based genome editing delivery system for cancer treatment: A review of fundamentals and applications. J Control Release Jiang Y, Sun R, Zhang J, Wang C, Chen X, Wu D. PMID: 43009024 [PubMed - as supplied by publisher]
	Robotic pancreatic enucleation versus laparoscopic pancreatic enucleation: a meta-analysis. J Robot Surg Shi J, Zhu C, Zhou Y. PMID: 43007558 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 62167

Page 1 of 3109



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy